FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Ocular Implant topics
Ocular Implant
Intraocular
Anterior Chamber
Ocular Implants
Intraocular Pressure
Anterior Chamber Of The Eye
Implantation
Biodegradable
Drug Delivery System
Bevacizumab
Medical Device
Multiple Stents
Aqueous Humor
Visualization
Instruments

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Ocular Implant patents



      
           
This page is updated frequently with new Ocular Implant-related patents. Subscribe to the Ocular Implant RSS feed to automatically get the update: related Ocular RSS feeds.

Subscribe to updates on this page: Ocular Implant RSS RSS

Date/App# patent app List of recent Ocular Implant-related patents
04/17/14
20140107556
 Ocular implant with shape change capabilities patent thumbnailnew patent Ocular implant with shape change capabilities
Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications.
03/20/14
20140081195
 Expanding ocular implant devices and methods patent thumbnailExpanding ocular implant devices and methods
Disclosed herein are devices and methods related to implants for treating one or more physiological conditions of the eye. Some embodiments disclosed herein include an expandable ocular implant for implanting in an eye.
03/06/14
20140066831
 Ocular implant with stiffness qualities, methods of implantation and system patent thumbnailOcular implant with stiffness qualities, methods of implantation and system
Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway.
02/13/14
20140046439
 Implantable mems device and method patent thumbnailImplantable mems device and method
An implantable mems package for the treatment of an ocular condition is provided. The mems package includes an outer portion; an active portion attached to the outer portion, the active portion including a fluid regulating element having a moving element; and a fluidic channel at an interface of the outer portion and the active portion.
02/06/14
20140039510
 Tps tools and methods for the surgical placement of intraocular implants patent thumbnailTps tools and methods for the surgical placement of intraocular implants
Provided herein are alignment systems, computer-implemented systems and methods utilizing the same for planning an optimal surgical implantation of asymmetric optics into one or both eyes of a patient and/or correcting astigmatism thereof. The methods generally comprise obtaining reference data comprising the surgical procedure plan, the reference image and the corneal topographic measurements for the patient's eye, determining an optimal placement angle of an optical zone on the cornea from the reference data and placing the asymmetric optic into the eye to match the determined optimal placement angle.
02/06/14
20140038972
 Alpha-2 agonist polymeric drug delivery systems patent thumbnailAlpha-2 agonist polymeric drug delivery systems
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers.
02/06/14
20140035184
 Extended release biodegradable ocular implants patent thumbnailExtended release biodegradable ocular implants
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer..
01/30/14
20140031833
 Interocular injector patent thumbnailInterocular injector
An intraocular injector includes a syringe body having open-ended cone disposed in one end thereof along with a piston disposed in the body. A transparent implant holder having a lumen therein is aligned with an open-ended cone, a needle include a proximal end and a distal end with a bevel disposed on the distal end of the needle.
01/30/14
20140031408
 Biodegradable intravitreal tyrosine kinase implants patent thumbnailBiodegradable intravitreal tyrosine kinase implants
Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol.
01/09/14
20140012279
 Ocular implant applier and methods of use patent thumbnailOcular implant applier and methods of use
Described herein is a delivery device and methods for delivering an ocular implant into an eye. The delivery device includes a proximal handle portion; a distal delivery portion coupled to a distal end of the handle portion and configured to releasably hold an ocular implant and includes a sheath positioned axially over a guidewire; and a metering system configured to provide visual guidance regarding depth of advancement of an implant positioned on the guidewire into an anatomic region of the eye.
01/09/14
20140012177
Ocular implant with therapeutic agents and methods thereof
Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye.
01/09/14
20140010823
Method for determining optimum intraocular locations for drug delivery systems
A method for determining the optimum location for placement of an intraocular implant containing used to treat an ocular condition, particularly implants comprised of a biodegradable polymer and a therapeutic agent for the treatment of retinal tissue.. .
01/02/14
20140005782
Intraocular lens with accommodation
An accommodating intraocular implant apparatus is disclosed for implantation in the human eye. The apparatus includes an optic portion having a periphery and an optic axis, said optic portion lying substantially within an optic plane transverse to said optic axis; at least one flexible haptic extending from a point on or near the periphery of the optic portion; at least one flexible haptic having a fixation anchor portion distal to the periphery of the optic portion; and at least one flexible haptic having a centering anchor portion.
12/26/13
20130345808
Intraocular implants and related kits and methods
Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within schlemm's canal and that may restore or maintain at least partial patency of the canal without substantially interfering with transmural or transluminal fluid flow across the canal.
12/19/13
20130338563
Methods and apparatus for delivering ocular implants into the eye
A method of deploying an ocular implant into schlemm's canal of a human eye including the following steps: inserting a distal tip of a delivery tool within an anterior chamber of the eye through trabecular meshwork of the eye into schlemm's canal of the eye; and advancing an ocular implant through a curved portion and a distal opening of the delivery tool to place a body portion of the ocular implant in schlemm's canal and an inlet portion of the ocular implant in the anterior chamber.. .
12/12/13
20130331939
Intraocular implant and method for fixing same into an eye
An intraocular implant for use in a surgical procedure such as a cataract operation, or in a refractive-lens exchange surgery procedure, has a main portion and a peripheral portion peripheral to the main portion. The main portion is plate-like in shape and may be a lens or a plug for closing an aperture in the capsule of the eye.
12/12/13
20130331938
Intraocular implant
An intraocular implant for placement in the eye, e.g. As part of a cataract operation or crystalline lens extraction refractive operation, has at a peripheral portion of the implant a groove which engages with the lip of a single capsulotomy only formed in the lens capsule of the eye.
12/12/13
20130331937
Intraocular implant and method for fixing same into an eye
An intraocular implant for use in a surgical procedure such as a cataract operation, or in a refractive-lens exchange surgery procedure, has a main portion and a peripheral portion peripheral to the main portion. The main portion is plate-like in shape and may be a lens or a plug for closing an aperture in the capsule of the eye.
12/12/13
20130331936
Intraocular implant
An embodiment of the intraocular implant includes two portions, a single-focus or multi-focus optical central portion, and a haptic peripheral portion. The haptic peripheral portion is formed of two extensions extending diametrically with respect to the optical central portion, aimed at immobilizing the implant in the capsular bag by applying their end portions against the edges of the capsular bag, on the inner side thereof.
12/12/13
20130331761
Methods and apparatus for treating glaucoma
An ocular implant for treating glaucoma is provided, which may include any number of features. More particularly, the present invention relates to implants that facilitate the transfer of fluid from within one area of the eye to another area of the eye.
11/21/13
20130310930
Ocular implant with double anchor mechanism
The invention relates generally to medical devices and methods for the treatment of ocular disorders. An ocular implant having an inlet portion with a first anchor and an outlet portion with a second anchor is provided.
11/21/13
20130308186
Extended depth field optics with variable pupil diameter
Apparatus and methods to increase the depth of field in human vision in order to correct for loss in refocusing ability. Optics variations, such as changes in thickness, shape, or index of refraction of contact lenses, intraocular implants, or the shape of the cornea or eye lens, affect the phase, or wavefront, of the light perceived by the eye.
11/14/13
20130304205
Intraocular lens cell migration inhibition system
Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye..
11/07/13
20130295157
Ocular implant made by a double extrusion proces
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end plga, and deliver active agents into an ocular region without a high burst release..
10/31/13
20130289467
Drug eluting ocular implant
Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device..
10/24/13
20130281910
Ocular implant system
The invention relates generally to medical devices and methods for reducing the intraocular pressure in an animal eye and, more particularly, to stent type devices for permitting aqueous outflow from the eye's anterior chamber and associated methods thereof for the treatment of glaucoma. Some aspects provide a self-trephining glaucoma stent and methods thereof which advantageously allow for a “one-step” procedure in which the incision and placement of the stent are accomplished by a single device and operation.
10/24/13
20130281908
Delivery system for ocular implant
A delivery system is disclosed which can be used to deliver an ocular implant into a target location within the eye via an ab interno procedure. In some embodiments, the implant can provide fluid communication between the anterior chamber and the suprachoroidal or supraciliary space while in an implanted state.
10/24/13
20130281907
Ocular implants for delivery into an anterior chamber of the eye
An ocular implant adapted to be disposed within schlemm's canal of a human eye with a body extending along a curved longitudinal central axis in a curvature plane, a first strut on one side of the implant and a second strut on an opposite side of the implant, the circumferential extent of the first strut with respect to the plane of curvature being greater than the circumferential extent of the second strut with respect to the plane of curvature. The invention also includes methods of using the implant..
10/24/13
20130281817
Direct visualization system for glaucoma treatment
A direct visualization (dv) system and methods for measuring one or more anatomical features of the eye, including a depth of the iridocorneal angle of the eye. The dv system can include a wire extending distally from a handle with the wire having one or more indicators for measuring anatomical features of the eye.
10/17/13
20130274689
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.. .
10/10/13
20130267497
Kinase inhibitors
The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed.. .
10/10/13
20130266630
Composition for intraocular implantation of bevacizumab
A solid, compressed pharmaceutical composition comprises i) a peptide active pharmaceutical ingredient, ii) a polysaccharide excipient and/or an albumin, and iii) an oligosaccharide excipient. The polysaccharide excipient may be hyaluronic acid, or the potassium salt thereof, and the oligosaccharide excipient may be trehalose..
09/26/13
20130253528
System and method for delivering multiple ocular implants
Systems and methods for delivering multiple ocular implants to reduce intraocular pressure are disclosed. The ocular implants can be implanted at multiple sites within a single human eye without requiring removal of the delivery apparatus from the eye.
09/26/13
20130253405
Ocular implant systems
Intraocular stents and applicators are disclosed for treating glaucoma. The stents are configured to extend between the anterior chamber of the eye and schlemm's canal for enhancing outflow of aqueous from the anterior chamber so as to reduce intraocular pressure.
09/26/13
20130253404
Ocular implant systems
Intraocular stents and applicators are disclosed for treating glaucoma. The stents are configured to extend between the anterior chamber of the eye and schlemm's canal for enhancing outflow of aqueous from the anterior chamber so as to reduce intraocular pressure.
09/19/13
20130245755
Installation and sealing of a battery on a thin glass wafer to supply power to an intraocular implant
Many modem implantable ophthalmic devices include electronic components, such as electro-active cells, that can leak harmful substances into the eye and/or surrounding tissue. In the implantable ophthalmic devices disclosed herein, electronic components are hermetically sealed to facilitate mechanically connecting components of an implantable ophthalmic device.
09/19/13
20130245532
Ocular implant system
The invention relates generally to medical devices and methods for reducing the intraocular pressure in an animal eye and, more particularly, to stent type devices for permitting aqueous outflow from the eye's anterior chamber and associated methods thereof for the treatment of glaucoma. Some aspects provide a self-trephining glaucoma stent and methods thereof which advantageously allow for a “one-step” procedure in which the incision and placement of the stent are accomplished by a single device and operation.
09/12/13
20130236557
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
Biocompatible intraocular implants, such as microparticles, include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers.
09/12/13
20130236526
Sustained release intraocular implants and methods for preventing retinal dysfunction
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers.
09/12/13
20130236525
Sustained release intraocular implants and related methods
Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers.
09/05/13
20130231740
Polymers and methods for ophthalmic applications
The present invention relates to novel methods and materials particularly useful for ophthalmic applications and to methods for making and using the same. More particularly, the present invention relates to relatively soft, optically transparent, foldable, high refractive index materials particularly suited for use in the production of intraocular lenses, contact lenses, and other ocular implants and to methods for manufacturing and implanting iols made therefrom..
09/05/13
20130231603
Ocular implants and methods for delivering ocular implants into the eye
An ocular implant is provided. In some embodiments, the ocular implant includes a body that is curved about a longitudinal central axis and a distal body portion that defines a longitudinal channel including a channel opening.
09/05/13
20130231449
Nanohybrid polymers for ophthalmic applications
The present invention relates to novel materials particularly useful for ophthalmic applications and methods for making and using the same. More particularly, the present invention relates to relatively soft, optically transparent, foldable, high refractive index materials particularly suited for use in the production of intraocular lenses, contact lenses, and other ocular implants and to methods for manufacturing and using the same..
09/05/13
20130231318
Ocular implant made by a double extrusion process
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end plga, and deliver active agents into an ocular region without a high burst release..
08/29/13
20130226292
Islet storing intraocular implant, method of using the same and kit including the same
An intraocular implant that has an anterior portion, at least one haptic element designed to localize the intraocular implant within an eye, a posterior portion, and an islet storage feature coupled to the anterior and posterior portions is disclosed. The interior of the islet storage feature is accessible from the anterior portion.
08/29/13
20130226193
Ocular implant insertion apparatus and methods
An exemplary ocular implant insertion system includes a case and a preloaded ocular implant insertion apparatus. The apparatus includes first and second movable structures that move the ocular implant in a predetermined sequence.
08/15/13
20130211312
Prefilled ocular implants and methods
A drainage device for implantation in an eye of a patient to treat an ocular condition includes a first tube configured to extend into an anterior chamber of the eye and convey aqueous humor from the anterior chamber. An exit portion is in fluid communication with the distal end portion.
08/15/13
20130210862
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol.
08/15/13
20130209538
Biodegradable ocular implant
The present invention relates to a biodegradable ocular implant for sustained drug delivery, comprising a first layer comprising a first biodegradable polymer, wherein the first layer contains a drug dispersed or dissolved therein. A multi-layered biodegradable ocular implant is also disclosed..
07/04/13
20130172804
Glaucoma treatment method
An ocular implant adapted to reside at least partially in a portion of schlemm's canal of an eye. In some embodiments the implant has a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches.
06/20/13
20130158561
Intravitreal application
An assembly for implanting ocular implants into a mammalian eye is provided. The assembly generally includes a cannula having a curved distal end, an injector mechanism coupled to the cannula for linearly moving one or more implant segments in the cannula toward the curved distal end, and a rotator mechanism for rotating the cannula about a longitudinal axis thereof..
06/20/13
20130158462
Delivering ocular implants into the eye
A method of deploying an ocular implant into schlemm's canal of an eye. The method includes the steps of inserting a distal end of a cannula through a cornea of the eye and into an anterior chamber of the eye, the cannula having a distal opening extending from the distal end and through a side wall; placing the distal opening of the cannula into fluid communication with schlemm's canal; advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the cannula distal opening.
06/20/13
20130158381
External pressure measurement system and method for an intraocular implant
An iop monitoring device for implantation in an eye of a patient may include a first tube having a first opening, the first tube being configured to extend into an anterior chamber of the eye and extend to a first sensor outside the anterior chamber. The first sensor may be in fluid communication with the first opening of the first tube.


Popular terms: [SEARCH]

Ocular Implant topics: Ocular Implant, Intraocular, Anterior Chamber, Ocular Implants, Intraocular Pressure, Anterior Chamber Of The Eye, Implantation, Biodegradable, Drug Delivery System, Bevacizumab, Medical Device, Multiple Stents, Aqueous Humor, Visualization, Instruments

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Ocular Implant for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ocular Implant with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.258

3769

2 - 1 - 75